Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Allergan Pays $2bn-Plus For Zeltiq, Expanding Aesthetics Business

Feb 13 2017

• By Reed Miller

Related Content

How Open Science Is Keeping Allergan's R&D Pipeline Strong

Nov 11 2016

Allergan Adds Accretive Aesthetics Assets In $2.9bn LifeCell Acquisition

Dec 21 2016

Related Companies

Allergan plc

ZELTIQ Aesthetics, Inc.

Allergan, Inc.

Allergan plc

Additional Topics

Deals Companies Commercial Aesthetics Medical Device

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window